Journal of Family and Reproductive Health 2014. 8(4):169-173.

Association between Angiotensinogen M235T Polymorphism and Preeclampsia in Iranian Pregnant Women.
Raha Afshariani, Jamshid Roozbeh, Maryam Sharifian, Mahbobeh Ghaedi, Alamtaj Samsami Dehaghani, Abbas Ghaderi

Abstract


Objective:To determine the possible association between the M235T variant of angiotensinogen gene and preeclampsia in Iranian preeclamtic women with hypertension during pregnancy. Mand methods:During a case control study, we used polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) analysis to investigate the association between M235T polymorphism in preeclamtic women compared to normotensive controls.
Results:The M235T polymorphism was significantly associated with increased preeclampsia risk in the studied population as supported by a p value of 0.017 and chi-square value of 8.12. The frequency of mutated allele and genotype distribution showed a significant difference between preeclamtic women and control groups.
Conclusion:The result indicates that the AGT M235T polymorphism plays a significant role in preeclampsia observed in selected Iranian preeclamtic women, and it can be considered as a major risk factor for preeclampsia.


Keywords


Angiotensinogen M235T Polymorphism; Preeclampsia

Full Text:

PDF

References


Cooper DW, Brennecke SP, Wilton AN. Genetics of preeclampsia.Hypertension Pregnancy 1993; 12:1–23.

Roberts JM, Pearson G, Cutler J, Lindheimer M, NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437-45.

Qureshi AI, Frankel MR, Ottenlips JR, Stern BJ. Cerebral hemodynamics in preeclampsia and eclampsia. Arch Neurol. 1996;53:1226-31.

Bouba I, Makrydimas G, Kalaitzidis R, Lolis DE, Siamopoulos KC, Georgiou I. Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003;110:8-11.

Sutherland A, Cooper DW, Howie PW, Liston WA, MacGillivray I. The incidence of severe preeclampsia amongst mothers and mothersin-law of preeclamptic and controls. Br J Obstet Gynaecol 1981;88:785–91.

Gant N, Gilstrap. Hypertension in pregnancy. ACOG. January Technical Bulletin 219, 1996

Kim YJ, Park MH, Park HS, Lee KS, Ha EH, Pang MG. Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin- converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women. Eur J Obstet Gynecol Reprod Biol. 2004; 116: 48-53.

Broughton PF. The renin angiotensin system in normal and hypertensive pregnancies. In: Rubin PC, editor. Handbook of hypertension. Amsterdam: Elsevier; 1988: 118–51.

Choi H, Kang JY, Yoon HS, Han SS, Whang CS, Moon IG, Et al. Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci 2004; 19: 253-7.

Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235

Thr allele of the human angiotensinogen gene.Hum Mol Genet 1993; 2: 609-10.

Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al., M235T variant of the human angiotensinogen gene in unselected hypertensive patients, J Hypertens Suppl 1993; 11: S80-1.

Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4: 59-61.

Arngrímsson R, Sigurõardóttir S, Frigge ML, Bjarnadóttir RI, Jónsson T, Stefánsson H, et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999; 8:1799-805.

Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW. Angiotensinogen gene variation in a population case-control study of preeclampsia/ eclampsia in Australians and Chinese. Electrophoresis 1997; 18: 1646-9.

Shim SS, Shim JY, Lim JH, Park JS, Jun JK, Bai KB, et al. Molecular biological approach to find out the etiology of hypertensive disorder in pregnancy: analysis of the polymorphism in the promoter of human angiotensinogen gene in Korean population. Korean J Obstet Gynecol 2003; 46: 1486-92.

National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163: 1691–712.

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4.

Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 1989; 161: 735-41.

Begum MR, Akhter S, Begum A, Khatun M, Quadir E, Choudhury SB. Conservative management of eclampsia and severe pre-eclampsia--A Bangladesh experience. Medscape Womens Health 2002 ;7: 1.

Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000; 79: 963-7.

Mignini LE, Villar J, Khan KS. Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 2006; 194:317-21.

August P, Lenz T, Ales KL, Druzin ML, Edersheim TG, Hutson JM,et al. Longitudinal study of the renin- angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990; 163: 1612-21.

Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvascular Research 2008 ;75:1-8.

Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.

Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-6.

Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999; 180: 95–102.

Tamura T, Johanning GL, Goldenberg RL, Johnston KE, DuBard MB. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 1996; 88: 497-502.

Arngrímsson R, Purandare S, Connor M, Walker JJ, Björnsson S, Soubrier F, et al. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet 1993; 4:114-5.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.